Open AccessHRQoL improves in treatment‐naïve HIV‐1 subjects initiated on lopinavir/ritonavir (LPV/r) with raltegravir (RAL) or tenofovir/emtricitabine (TDF/FTC)
Author(s) -
Baran RW,
Dietz B,
Fredrick LM,
Tian M,
Podsadecki T
Publication year - 2010
Publication title -
journal of the international aids society
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.724
H-Index - 62
ISSN - 1758-2652
DOI - 10.1186/1758-2652-13-s4-p8
Subject(s) - raltegravir , medicine , emtricitabine , lopinavir , ritonavir , quality of life (healthcare) , viral load , tenofovir , human immunodeficiency virus (hiv) , antiretroviral therapy , immunology , nursing
7‐11 November 2010, Tenth International Congress on Drug Therapy in HIV Infection, Glasgow, UK